Aquestive Therapeutics, Inc.

Ownership Transactions Reported by 24 Insiders

Symbol
AQST on Nasdaq
Industry
Pharmaceutical Preparations
Location
30 Technology Drive, Warren, NJ

Insiders trading volume in the past year

Aquestive Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Alexander Mark Schobel Chief Innovation/Tech Officer $5.91M Mar 15, 2024
Daniel Barber President and CEO, Director $5.57M -$554K -9.04% Sep 26, 2025
Carl N. Kraus Chief Medical Officer $1.98M -$142K -6.7% Oct 15, 2025
Peter E. Boyd SVP IT, HR, & Communications $1.88M -$213K -10.2% Oct 15, 2025
Cassie Jung Chief Operating Officer $1.7M -$785K -31.6% Oct 15, 2025
Lori Braender Chief Legal Officer $1.07M Mar 7, 2025
Douglas K. Bratton 10%+ Owner $1.03M Dec 2, 2024
A. Ernest Toth Jr Chief Financial Officer $899K Mar 7, 2025
Stephen Wargacki Chief Science Officer $873K Mar 7, 2025
Sherry Korczynski Chief Commercial Officer $700K Aug 14, 2025
Keith J. Kendall CEO and President, Director $516K Mar 10, 2022
Melina Cioffi SVP, Regulatory Affairs $479K May 15, 2025
John Cochran Director $442K Jun 11, 2025
Gregory B. Brown Director $368K Jun 11, 2025
Abigail L. Jenkins Director $143K Jun 11, 2025
Marco Taglietti Director $143K Jun 11, 2025
Timothy E. Morris Director $143K Jun 11, 2025
Julie Krop Director $143K Jun 11, 2025
Ken W. Marshall SVP, Chief Commercial Officer $123K Aug 9, 2023
Costa Santo J Director $104K Jun 20, 2024
James S. Scibetta Director $25.6K Jun 15, 2021
Kenneth Truitt Chief Medical Officer Sep 6, 2022
Theresa Wood SVP-HR and Org. Development Mar 10, 2022
Nancy Lurker Director Jun 15, 2021

Recent Insider Transactions by Companies or Individuals for Aquestive Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.